Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Africa CDC says Congo Ebola outbreak still not under control

    November 16, 2026

    UAE and Timor-Leste presidents discuss stronger bilateral ties

    November 16, 2026

    UAE President, Arab League chief discuss regional security

    November 14, 2026
    • Home
    • Contact Us
    The Straits EchoThe Straits Echo
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    The Straits EchoThe Straits Echo
    Home » Prostate cancer breakthrough: Russia develops first theranostic dual drug
    Health

    Prostate cancer breakthrough: Russia develops first theranostic dual drug

    March 14, 2025
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    Scientists at Tomsk Polytechnic University (TPU) have developed and patented Russia’s first theranostic pair original radiopharmaceuticals designed for both the diagnosis and treatment of prostate cancer. According to the TPU press service, the initial phase of pilot clinical trials has been successfully completed, marking a significant advancement in Russian oncology research.

    The development is part of a growing field known as theranostics, which combines diagnostic and therapeutic applications into a single approach to cancer treatment. Until now, only two theranostic molecules have been available globally, both developed by foreign companies, targeting neuroendocrine tumors and prostate cancer.

    The Tomsk scientists‘ achievement establishes Russia’s first domestically developed alternative in this field. Roman Zelchan, senior researcher at the Oncoteranostics Research Centre at TPU’s Research School of Chemical and Biomedical Technologies, emphasized the significance of this breakthrough. “We can safely say that Tomsk Polytechnic University has developed the first domestic theranostic pair,” he stated.

    Understanding theranostics: The future of cancer treatment

    Zelchan is also a leading research associate at the Department of Radionuclide Therapy and Diagnostics at the Tomsk Research Institute of Oncology, part of the Tomsk Medical Research Centre. The newly developed radiopharmaceuticals are based on the BQ-PSMA compound, enabling both diagnostic and therapeutic applications. When combined with the diagnostic radioactive isotope technetium-99m, the compound functions as a “signal beacon” that identifies tumor cells.

    The therapeutic version, incorporating lutetium-177, enhances the compound’s ability to target and destroy cancer cells effectively. Prostate cancer remains one of the most commonly diagnosed cancers worldwide, affecting approximately one in eight men during their lifetime. The introduction of this Russian theranostic technology could expand treatment options and improve outcomes for patients.

    The researchers at TPU believe their development represents a major step in advancing personalized cancer treatment within Russia and beyond. With further clinical trials and regulatory approvals, the theranostic pair could potentially become an integral part of modern oncology protocols. This breakthrough aligns with a broader push in Russia to advance domestic pharmaceutical and medical technology sectors, reducing reliance on foreign innovations. – By Eurasian Newswire News Desk.

    Related Posts

    Africa CDC says Congo Ebola outbreak still not under control

    November 16, 2026

    WHO reports 67 yellow fever cases in nine African countries

    November 7, 2026

    Bangladesh dengue deaths reach 418 after deadliest month of 2026

    November 2, 2026

    DR Congo Ebola death toll climbs to 5,340 as cases reach 10,351

    November 2, 2026

    DR Congo Ebola cases top 10,000 in fastest-growing outbreak

    October 28, 2026

    Zambezi Region records 33,944 malaria cases since January

    October 26, 2026
    Latest News

    Africa CDC says Congo Ebola outbreak still not under control

    November 16, 2026

    – The Ebola outbreak in the Democratic Republic of the Congo is still not under control six months after it was declared, the Africa Centres for Disease Control and Prevention said. Africa CDC Director-General Jean Kaseya told Reuters on Sunday

    UAE and Timor-Leste presidents discuss stronger bilateral ties

    November 16, 2026

    UAE President, Arab League chief discuss regional security

    November 14, 2026

    AfDB backs Morocco reforms and climate resilience with €434.4m

    November 14, 2026

    China, Türkiye and Ethiopia launch carbon credit initiative

    November 13, 2026

    DP World partner ATI wins 25-year Manila port renewal

    November 13, 2026

    EU and Nigeria sign agreement to speed up migrant returns

    November 12, 2026

    ADB flags $264 billion yearly ASEAN infrastructure gap

    November 12, 2026

    Modi tells Zelenskyy India ready to help end Ukraine conflict

    November 11, 2026
    © 2026 The Straits Echo | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.